Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
REVIEW

Psychosocial aspects of anal cancer screening: a review and recommendations

J. M. B. Landstra A D E , J. Ciarrochi B and F. P. Deane A C
+ Author Affiliations
- Author Affiliations

A School of Psychology, University of Wollongong, Wollongong, NSW 2522, Australia.

B School of Social Sciences and Psychology University of Western Sydney, Locked Bag 1797, Penrith, NSW 2751, Australia.

C Illawarra Institute for Mental Health, University of Wollongong, Wollongong, NSW 2522, Australia.

D HIV, Hepatitis C and Mental Health, St Vincent’s Hospital, Victoria Street, Darlinghurst, NSW 2010, Australia.

E Corresponding author. Email: jodielandstra@gmail.com

Sexual Health 9(6) 620-627 https://doi.org/10.1071/SH11169
Submitted: 30 November 2012  Accepted: 29 May 2012   Published: 10 September 2012

Abstract

Cancer screening programs have the potential to decrease psychosocial wellbeing. This review investigates the evidence that anal cancer screening has an impact on psychosocial functioning and outlines considerations for supporting participants. The review suggested that screening has no significant effect on general mental health but may increase cancer-specific worry. Having worse anal or HIV symptoms, being younger, higher baseline distress or worse histology results were predictive of greater worry. The findings suggest the need to increase education campaigns, particularly targeting those with HIV infection and men who have sex with men. There is a need to develop a consensus on measuring the psychosocial impact of screening and stepped care approaches for responding to any resulting distress.

Additional keywords: HIV, HPV, mental health, wellbeing.


References

[1]  New York State Department of Public Health AIDS Institute (NYSDPHAI). Clinical guidelines: human papillomavirus: HIV clinical resource. New York: NYSDPHAI; 2007. Available online at: http://hivguidelines.org/clinical-guidelines/adults/management-of-stis-in-hiv-infected-patients/human-papillomavirus-hpv/ [verified November 2011].

[2]  Herat A, Whitfeld M, Hillman R. Anal intraepithelial neoplasia and anal cancer in dermatological practice. Aust J Dermatol 2007; 48 143–55.
Anal intraepithelial neoplasia and anal cancer in dermatological practice.Crossref | GoogleScholarGoogle Scholar |

[3]  Palefsky J. Human papillomavirus infection in HIV-infected persons. Top HIV Med 2007; 15 130–3.
| 17720998PubMed |

[4]  Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119 5–19.
Anal cancer and cervical cancer screening: key differences.Crossref | GoogleScholarGoogle Scholar | 21319310PubMed |

[5]  Chin-Hong PV, Berry JM, Su-Chun C, Catania JA, Da Costa M, Darragh TM, et al Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008; 149 300–63.
| 18765699PubMed |

[6]  Tinmouth J, Raboud J, Ali M, Malloch L, Su D, Sano M, et al The psychological impact of being screened for anal cancer in HIV-infected men who have sex with men. Dis Colon Rectum 2011; 54 352–9.
The psychological impact of being screened for anal cancer in HIV-infected men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 21304309PubMed |

[7]  Nathan M, Hickey N, Mayuranathan L, Vowler SL, Singh N. Treatment of anal human papillomavirus-associated disease: a long term outcome study. Int J STD AIDS 2008; 19 445–9.
Treatment of anal human papillomavirus-associated disease: a long term outcome study.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1cvgsFWgtA%3D%3D&md5=eb22cfe27c17562ba75c054ab74c0567CAS | 18574114PubMed |

[8]  Botes LP, Jin FY, Bourne C, Pett S, Marriott D, Carr A, et al Participants’ perspectives of self-collected anal cytological swabs. Sex Health 2011; 8 257–8.
Participants’ perspectives of self-collected anal cytological swabs.Crossref | GoogleScholarGoogle Scholar | 21592444PubMed |

[9]  Hounsgaard L, Petersen LK, Pedersen BD. Facing possible illness detected through screening–experiences of healthy women with pathological cervical smears. Eur J Oncol Nurs 2007; 11 417–23.
Facing possible illness detected through screening–experiences of healthy women with pathological cervical smears.Crossref | GoogleScholarGoogle Scholar | 17604694PubMed |

[10]  Stewart-Brown S, Farmer A. Screening could seriously damage your health. BMJ 1997; 314 533–4.
Screening could seriously damage your health.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s3gvVOlsg%3D%3D&md5=c062c596abab248d73e90958dbffad1aCAS | 9055702PubMed |

[11]  McNaughton-Collins M, Fowler FJ, Caubet J-F, Bates DW, Lee JM, Hauser A, et al Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med 2004; 117 719–25.
Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result.Crossref | GoogleScholarGoogle Scholar | 15541320PubMed |

[12]  Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individuals’ risks of illness: a systematic review. Soc Sci Med 1999; 49 1571–98.
Psychological impact of predicting individuals’ risks of illness: a systematic review.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c%2FjvFerug%3D%3D&md5=fd7267279574ab48fdde3263ff68ba5dCAS | 10574231PubMed |

[13]  McCaffery KJ, Barratt AL. Assessing psychosocial/quality of life outcomes in screening: how do we do it better? J Epidemiol Community Health 2004; 58 968–70.
Assessing psychosocial/quality of life outcomes in screening: how do we do it better?Crossref | GoogleScholarGoogle Scholar | 15547053PubMed |

[14]  Barratt A, Mannes P, Irwig L, Trevena L, Craig J, Rychetnik L. Cancer screening. J Epidemiol Community Health 2002; 56 899–902.
Cancer screening.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD38npvFGlsw%3D%3D&md5=ba8e8fc79dbf5fb5964d3debd3f45defCAS | 12461108PubMed |

[15]  Szarewski A. Social and psychological aspects of cervical screening. Expert Rev Obstet Gynecol 2011; 6 37–44.
Social and psychological aspects of cervical screening.Crossref | GoogleScholarGoogle Scholar |

[16]  McNaughton-Collins M, Walker-Corkery E, Barry MJ. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990–2000. J Natl Cancer Inst 2004; 2004 78–101.
Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990–2000.Crossref | GoogleScholarGoogle Scholar |

[17]  Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of mammographic screening. A systematic review. Psychooncology 2005; 14 917–38.
The psychological impact of mammographic screening. A systematic review.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MrotVamtg%3D%3D&md5=cf9166cd7ee6722f697d7205c7080796CAS | 15786514PubMed |

[18]  Gray NM, Sharp L, Cotton SC, Masson LF, Little J, Walker LG, et al Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer 2006; 94 1253–62.
Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD283ks1Wgsw%3D%3D&md5=814482e9a856cdcb8029aa2a209b12c3CAS | 16622462PubMed |

[19]  French DP, Maissi E, Marteau TM. Psychological costs of inadequate cervical smear test results. Br J Cancer 2004; 91 1887–92.
Psychological costs of inadequate cervical smear test results.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2croslyhsg%3D%3D&md5=62e3e3a6c493bcbb2fd9d5b533fa86caCAS | 15534608PubMed |

[20]  Wardle J, Pernet A, Stephens D. Psychological consequences of positive results in cervical cancer screening. Psychol Health 1995; 10 185–94.
Psychological consequences of positive results in cervical cancer screening.Crossref | GoogleScholarGoogle Scholar |

[21]  Fowler FJ, Barry MJ, Walker-Corkery B, Caubet J-F, Bates DW, Jeong Min L, et al The impact of a suspicious prostate biopsy on patients’ psychological, socio-behavioral, and medical care outcomes. J Gen Intern Med 2006; 21 715–21.
The impact of a suspicious prostate biopsy on patients’ psychological, socio-behavioral, and medical care outcomes.Crossref | GoogleScholarGoogle Scholar | 16808772PubMed |

[22]  Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, et al Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int 2006; 98 777–82.
Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.Crossref | GoogleScholarGoogle Scholar | 16978272PubMed |

[23]  Essink-Bot M, de Koning HJ, Nijs HGT, Kirkels WJ, Schroder FH. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 1998; 90 925–31.
Short-term effects of population-based screening for prostate cancer on health-related quality of life.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1c3pvFaisQ%3D%3D&md5=b9123a9fb35620a9c1315a8beffbdb1bCAS | 9637143PubMed |

[24]  Carlsson S, Aus G, Wessman C, Hugosson J. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) – results from a prospective, population-based, randomised study. Eur J Canc 2007; 43 2109–16.

[25]  McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect 2006; 82 169–74.
Social and psychological impact of HPV testing in cervical screening: a qualitative study.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD287osFCrtw%3D%3D&md5=1b133d0fb93f27c0a86413c44cfc3eebCAS | 16581749PubMed |

[26]  Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int 2007; 100 544–51.
Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.Crossref | GoogleScholarGoogle Scholar | 17532857PubMed |

[27]  Pitts MK, Fox C, Willis J, Anderson J. What do gay men know about human papillomavirus? Australian gay men’s knowledge and experience of anal cancer screening and human papillomavirus. Sex Transm Dis 2007; 34 170–3.
What do gay men know about human papillomavirus? Australian gay men’s knowledge and experience of anal cancer screening and human papillomavirus.Crossref | GoogleScholarGoogle Scholar | 16837830PubMed |

[28]  D’Souza G, Cook RL, Ostrow D, Johnson-Hill LM, Wiley D, Silvestre T. Anal cancer screening behaviors and intentions in men who have sex with men. J Gen Intern Med 2008; 23 1452–7.
Anal cancer screening behaviors and intentions in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 18618198PubMed |

[29]  Reed AC, Reiter PL, Smith JS, Palefsky JM, Brewer NT. Gay and bisexual men’s willingness to receive anal Papanicolaou testing. Am J Public Health 2010; 100 1123–9.
Gay and bisexual men’s willingness to receive anal Papanicolaou testing.Crossref | GoogleScholarGoogle Scholar | 20395576PubMed |

[30]  Truesdale MD, Goldstone SE. The fear factor: drivers and barriers to follow-up screening for human papillomavirus-related anal cancer in men who have sex with men. Int J STD AIDS 2010; 21 482–8.
The fear factor: drivers and barriers to follow-up screening for human papillomavirus-related anal cancer in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3cfjsVentw%3D%3D&md5=ee9e2e77d308b287c3a4ede674cabbecCAS | 20852198PubMed |

[31]  Landstra JMB, Ciarrochi J, Deane FP, Botes LP, Hillman RJ. Psychosocial impact of anal cancer screening on HIV-infected men. Psycho-oncology
Psychosocial impact of anal cancer screening on HIV-infected men.Crossref | GoogleScholarGoogle Scholar |

[32]  Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005; 14 517–34.
The role of cancer worry in cancer screening: a theoretical and empirical review of the literature.Crossref | GoogleScholarGoogle Scholar | 15490428PubMed |

[33]  Gray NM, Sharp L, Cotton S, Masson LF, Little J, Walker LG, et al After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial. BJOG 2009; 116 1506–14.
After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial.Crossref | GoogleScholarGoogle Scholar |

[34]  McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004; 111 1437–43. [erratum appears in BJOG 2004 Dec; 111(12): 1489].
Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.Crossref | GoogleScholarGoogle Scholar | 15663132PubMed |

[35]  Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormal result of cervical smear test: a controlled trial. Br Med J (Clin Res Ed) 1990; 300 440
Anxiety caused by abnormal result of cervical smear test: a controlled trial.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK3c7pvFWmsg%3D%3D&md5=be94fe7517fe9c5cb4b895bb376e7af3CAS |

[36]  Wilson JD, Hines B. Nurse counselling for women with abnormal cervical cytology improves colposcopy and cytology follow up attendance rates. Sex Transm Infect 2000; 76 322
Nurse counselling for women with abnormal cervical cytology improves colposcopy and cytology follow up attendance rates.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3cvns1ygsg%3D%3D&md5=a559364f002a29b7f9a897e219999e48CAS | 11026900PubMed |

[37]  Bower P, Gilbody S. Stepped care in psychological therapies: access, effectiveness and efficiency – narrative literature review. Br J Psychiatry 2005; 186 11–7.
Stepped care in psychological therapies: access, effectiveness and efficiency – narrative literature review.Crossref | GoogleScholarGoogle Scholar | 15630118PubMed |

[38]  Lauver DR, Kruse K, Baggot A. Women’s uncertainties, coping, and moods regarding abnormal Papanicolaou results. J Womens Health Gend Based Med 1999; 8 1103–1112.
Women’s uncertainties, coping, and moods regarding abnormal Papanicolaou results.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c%2FivFequw%3D%3D&md5=cc23da33665fc243873aacc7bb0823e9CAS | 10565669PubMed |

[39]  Barnoy S, Bar-Tal Y, Treister L. Effect of unrealistic optimism, perceived control over disease, and experience with female cancer on behavioral intentions of Israeli women to undergo screening tests. Cancer Nurs 2003; 26 363–9.
Effect of unrealistic optimism, perceived control over disease, and experience with female cancer on behavioral intentions of Israeli women to undergo screening tests.Crossref | GoogleScholarGoogle Scholar | 14710797PubMed |

[40]  Larsen IK, Grotmol T, Almendingen K, Hoff G. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol 2007; 5 477–83.
Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial.Crossref | GoogleScholarGoogle Scholar | 17363335PubMed |